5 completed. 4 Not applicable, 1 Phase 1.
By phase and status
Follow Janumet XR: new trials by email Literature Review of Janumet XR trials Research Report on Janumet XR
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|
Clinical Study to Determine Bioequivalence Between Two Oral Medications of Sitagliptin/Metformin in Prolonged-release Tablets With 100 mg/1000 mg in Healthy Subjects, Fed Study.
Janumet XR, Sitagliptin/Metformin FDC - Bioequivalance | Not applicable | Completed | ADIUM | 46 | 2025-12-08 | 2026-08-14 |
Clinical Study to Determine Bioequivalence Between Two Oral Medications of Sitagliptin/Metformin in Prolonged-release Tablets With 100 mg/1000 mg in Healthy Subjects, Fast Study.
Janumet XR, Sitagliptin/Metformin FDC - Bioequivalance | Not applicable | Completed | ADIUM | 46 | 2025-12-03 | 2026-08-14 |
Clinical Study to Determine Bioequivalence Between Two Oral Medications of Sitagliptin/Metformin in Prolonged-release Tablets With 50 mg/1000 mg in Healthy Subjects, Fed Study.
Janumet XR, Sitagliptin/Metformin FDC - Bioequivalence | Not applicable | Completed | ADIUM | 46 | 2025-11-24 | 2026-08-14 |
Clinical Study to Determine Bioequivalence Between Two Oral Medications of Sitagliptin/Metformin in Prolonged-release Tablets With 50 mg/1000 mg in Healthy Subjects, Fast Study.
Sitagliptin/Metformin FDC, Janumet XR - Bioequivalance | Not applicable | Completed | ADIUM | 46 | 2025-11-19 | 2026-08-14 |
A Study to Assess the Pharmacokinetics and the Ability for Pediatric Participants With Type 2 Diabetes to Swallow MK-0431A XR Tablets (MK-0431A-296)
Sitagliptin/metformin XR, Placebo, Metformin - Type 2 Diabetes Mellitus | Phase 1 | Completed | Merck Sharp & Dohme LLC | 25 | 2012-07-18 | 2020-10-28 |
Conditions studied
Diabetes Mellitus, Type 2 (1)
Sponsors
ADIUM (4) · Merck Sharp & Dohme LLC (1)
Countries
Mexico (4)